Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human TRPV2 ELISA Kit (AC3165)
Cat.#: ASET-1754
Specifications
Description Human TRPV2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human TRPV2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.98 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1525 Human beta Catenin ELISA Kit (AC2936) Quantitative inquiry ASET-1445 Mouse ABCA7 ELISA Kit (AC2856) Quantitative inquiry ASET-2366 Human Wnt3a ELISA Kit (AC3777) Quantitative inquiry ASET-2154 Human IMPA2 ELISA Kit (AC3565) Quantitative inquiry ASET-1067 Human QPRT ELISA Kit (AC2478) Quantitative inquiry ASET-1352 Rabbit Apolipoprotein E ELISA Kit (AC2763) Quantitative inquiry ASET-2483 Human Iba1 ELISA Kit (AC3894) Quantitative inquiry ASET-2095 Rat Dopamine D2 Receptor ELISA Kit (AC3506) Quantitative inquiry ASET-2504 Rat 160 kD Neurofilament Medium ELISA Kit (AC3915) Quantitative inquiry ASET-1760 Human GLP-1R ELISA Kit (AC3171) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket